Neutralizing human anti-IGFR antibody This application is incorporated by reference in US Provisional Application 60 / 383,459 (filed May 24, 2002), US Provisional Application 60 / 393,214 (filed July 2, 2002), and United States This application claims the priority of provisional application 60 / 436,254 (filed on December 23, 2002), each of which is incorporated herein in its entirety.

摘要

The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1) . The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.